The aqueous extract of Gentianella acuta improves isoproterenol‑induced myocardial fibrosis via inhibition of the TGF‑β1/Smads signaling pathway

Yang,Hong‑Xia; Xu,Geng‑Rui; Zhang,Chuang; Sun,Jia‑Huan; Zhang,Yue; Song,Jun‑Na; Li,Yun‑Feng; Liu,Yu; Li,Ai‑Ying

doi:10.3892/ijmm.2019.4410

The aqueous extract of Gentianella acuta improves isoproterenol‑induced myocardial fibrosis via inhibition of the TGF‑β1/Smads signaling pathway

Authors:
- Hong‑Xia Yang
- Geng‑Rui Xu
- Chuang Zhang
- Jia‑Huan Sun
- Yue Zhang
- Jun‑Na Song
- Yun‑Feng Li
- Yu Liu
- Ai‑Ying Li
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, College of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China, Department of Medical Laboratory Science, College of Integration of Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China, Department of Medicinal Plant, College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China
Published online on: November 21, 2019 https://doi.org/10.3892/ijmm.2019.4410
Pages: 223-233
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gentianella acuta (G. acuta) is one of the most commonly used herbs in Chinese Mongolian medicine for the treatment of heart disease. Previously, it was found that G. acuta ameliorated cardiac function and inhibited isoproterenol (ISO)‑induced myocardial fibrosis in rats. In this study, the underlying anti‑fibrotic mechanism of G. acuta was further elucidated. Histopathological changes in the heart were observed by hematoxylin‑eosin, Masson trichrome and wheat germ agglutinin staining. Relevant molecular events were investigated using immunohistochemistry and western blotting. The results revealed that G. acuta caused improvements in myocardial injury and fibrosis. G. acuta also inhibited collagens I and III and α‑smooth muscle actin production in heart tissue. G. acuta downregulated the expression of transforming growth factor β1 (TGF‑β1) and notably inhibited the levels of phosphorylation of TGF‑β receptors I and II. Furthermore, G. acuta caused downregulation of the intracellular mothers against decapentaplegic homolog (Smads)2 and 4 expression and inhibited Smads2 and 3 phosphorylation. The results further demonstrated that the mechanism underlying anti‑myocardial fibrosis effects of G. acuta was based upon the suppression of the TGF‑β1/Smads signaling pathway. Therefore, G. acuta may be a potential therapeutic agent for ameliorating myocardial fibrosis.

View Figures

View References

1	Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, Todiere G, Srebot V, Passino C, Aquaro GD, et al: Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: A contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging. 6:790–799. 2013. View Article : Google Scholar : PubMed/NCBI
2	Dixon JA and Spinale FG: Pathophysiology of myocardial injury and remodeling: Implications for molecular imaging. J Nucl Med. 51(Suppl3r 1): 102S–106S. 2010. View Article : Google Scholar : PubMed/NCBI
3	Li L, Zhao Q and Kong W: Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol. 68-69:490–506. 2018. View Article : Google Scholar : PubMed/NCBI
4	Frangogiannis NG: Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 65:70–99. 2019. View Article : Google Scholar
5	Czubryt MP: Common threads in cardiac fibrosis, infarct scar formation, and wound healing. Fibrogenesis Tissue Repair. 5:192012. View Article : Google Scholar : PubMed/NCBI
6	Meyers TA and Townsend D: Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart. Am J Physiol Heart Circ Physiol. 308:H303–H315. 2015. View Article : Google Scholar :
7	Raman B, Ariga R, Spartera M, Sivalokanathan S, Chan K, Dass S, Petersen SE, Daniels MJ, Francis J, Smillie R, et al: Progression of myocardial fibrosis in hypertrophic cardiomyopathy: Mechanisms and clinical implications. Eur Heart J Cardiovasc Imaging. 20:157–167. 2019. View Article : Google Scholar :
8	Goumans MJ and Ten Dijke P: TGF-β signaling in control of cardiovascular function. Cold Spring Harb Perspect Biol. 10:a0222102018. View Article : Google Scholar
9	Yue Y, Meng K, Pu Y and Zhang X: Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract. 133:124–130. 2017. View Article : Google Scholar : PubMed/NCBI
10	Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND and Zhao YY: New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 292:76–83. 2018. View Article : Google Scholar : PubMed/NCBI
11	Leask A: Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res. 106:1675–1680. 2010. View Article : Google Scholar : PubMed/NCBI
12	Gyorfi AH, Matei AE and Distler JHW: Targeting TGF-β signaling for the treatment of fibrosis. Matrix Biol. 68-69:8–27. 2018. View Article : Google Scholar
13	Wunir, Chunliang and Khasbagan: Ewenki folk medicinal plants and its comparison with Mongolian medicine. Chin J Ethnomed Ethnopharm. 18:156–158. 2009.In Chinese.
14	Liu Y, Ni Y, Ruan J, Qu L, Yu H, Han L, Zhang Y and Wang T: Bioactive gentixanthone and gentichromone from the whole plants of Gentianella acuta (Michx.) Hulten. Fitoterapia. 113:164–169. 2016. View Article : Google Scholar : PubMed/NCBI
15	Wang Z, Wu G, Liu H, Xing N, Sun Y, Zhai Y, Yang B, Kong AT, Kuang H and Wang Q: Cardioprotective effect of the xanthones from Gentianella acuta against myocardial ischemia/reperfusion injury in isolated rat heart. Biomed Pharmacother. 93:626–635. 2017. View Article : Google Scholar : PubMed/NCBI
16	Wang Z, Wu G, Yu Y, Liu H, Yang B, Kuang H and Wang Q: Xanthones isolated from Gentianella acuta and their protective effects against H₂O₂-induced myocardial cell injury. Nat Prod Res. 32:2171–2177. 2018. View Article : Google Scholar
17	Yu Y, Wang ZB, Zhai YD, Song PY, Wang QH, Yang BY and Kuang H: Lignan glycosides from Gentianella acuta (Michx.) Hulten and their protective effects against H₂O₂-induced apop-tosis in H9c2 cardiomyoblast. Rec Nat Prod. 8:234–241. 2014.
18	Li AY, Wang JJ, Yang SC, Zhao YS, Li JR, Liu Y, Sun JH, An LP, Guan P and Ji ES: Protective role of Gentianella acuta on isoprenaline induced myocardial fibrosis in rats via inhibition of NF-κB pathway. Biomed Pharmacother. 110:733–741. 2019. View Article : Google Scholar
19	Xu SY, Bian RL and Chen X: Experimental methodology of pharmacology. People's Medical Publishing House; Beijing: 1982
20	Blanchard OL and Smoliga JM: Translating dosages from animal models to human clinical trials-revisiting body surface area scaling. FASEB J. 29:1629–1634. 2015. View Article : Google Scholar : PubMed/NCBI
21	Zhou H, Chen X, Chen L, Zhou X, Zheng G, Zhang H, Huang W and Cai J: Anti-fibrosis effect of scutellarin via inhibition of endothelial-mesenchymal transition on isoprenaline-induced myocardial fibrosis in rats. Molecules. 19:15611–15623. 2014. View Article : Google Scholar : PubMed/NCBI
22	Wan Y, Xu L, Wang Y, Tuerdi N, Ye M and Qi R: Preventive effects of astragaloside IV and its active sapogenin cycloas-tragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome. Eur J Pharmacol. 833:545–554. 2018. View Article : Google Scholar : PubMed/NCBI
23	Chen J, Zhan Y, Wang Y, Han D, Tao B, Luo Z, Ma S, Wang Q, Li X, Fan L, et al: Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats. Acta Biomater. 80:154–168. 2018. View Article : Google Scholar : PubMed/NCBI
24	Koga M, Kuramochi M, Karim MR, Izawa T, Kuwamura M and Yamate J: Immunohistochemical characterization of myofibro-blasts appearing in isoproterenol-induced rat myocardial fibrosis. J Vet Med Sci. 81:127–133. 2019. View Article : Google Scholar
25	Daley WP and Yamada KM: ECM-modulated cellular dynamics as a driving force for tissue morphogenesis. Curr Opin Genet Dev. 23:408–414. 2013. View Article : Google Scholar : PubMed/NCBI
26	Gyöngyösi M, Winkler J, Ramos I, Do QT, Firat H, McDonald K, González A, Thum T, Díez J, Jaisser F, et al: Myocardial fibrosis: Biomedical research from bench to bedside. Eur J Heart Fail. 19:177–191. 2017. View Article : Google Scholar : PubMed/NCBI
27	Voorhees AP and Han HC: Biomechanics of cardiac function. Compr Physiol. 5:1623–1644. 2015. View Article : Google Scholar : PubMed/NCBI
28	Nielsen SH, Mouton AJ, DeLeon-Pennell KY, Genovese F, Karsdal M and Lindsey ML: Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes. Matrix Biol. 75-76:43–57. 2019. View Article : Google Scholar
29	Chistiakov DA, Orekhov AN and Bobryshev YV: The role of cardiac fibroblasts in post-myocardial heart tissue repair. Exp Mol Pathol. 101:231–240. 2016. View Article : Google Scholar : PubMed/NCBI
30	van Putten S, Shafieyan Y and Hinz B: Mechanical control of cardiac myofibroblasts. J Mol Cell Cardiol. 93:133–142. 2016. View Article : Google Scholar
31	Gabbiani G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 200:500–503. 2003. View Article : Google Scholar : PubMed/NCBI
32	Dobaczewski M, Chen W and Frangogiannis NG: Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol. 51:600–606. 2011. View Article : Google Scholar
33	Shinde AV, Humeres C and Frangogiannis NG: The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta Mol Basis Dis. 1863:298–309. 2017. View Article : Google Scholar
34	Luo K and Lodish HF: Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues. EMBO J. 16:1970–1981. 1997. View Article : Google Scholar : PubMed/NCBI
35	Li PF, He RH, Shi SB, Li R, Wang QT, Rao GT and Yang B: Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation. Biosci Rep. 39:BSR201819312019. View Article : Google Scholar
36	Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, Vagnozzi RJ, Liu R, Huynh T, Lee SJ, et al: Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis. J Clin Invest. 127:3770–3783. 2017. View Article : Google Scholar : PubMed/NCBI
37	Wang Y, Chu J, Yi P, Dong W, Saultz J, Wang Y, Wang H, Scoville S, Zhang J, Wu LC, et al: SMAD4 promotes TGF-β-independent NK cell homeostasis and maturation and antitumor immunity. J Clin Invest. 128:5123–5136. 2018. View Article : Google Scholar : PubMed/NCBI
38	Ding Z, Liu Y, Ruan J, Yang S, Yu H, Chen M, Zhang Y and Wang T: Bioactive constituents from the whole plants of Gentianella acuta (Michx.) Hulten. Molecules. 22:E13092017. View Article : Google Scholar : PubMed/NCBI
39	Feng CY, Wu Q, Yin DD, Li B, Li SS, Tang ZQ, Xu YJ and Wang LS: Determination of xanthones and flavonoids of methanol extracts obtained from different parts of the plants of three Gentianaceae species. J Pharm Biomed Anal. 161:455–463. 2018. View Article : Google Scholar : PubMed/NCBI
40	Ren K, Su H, Lv LJ, Yi LT, Gong X, Dang LS, Zhang RF and Li MH: Effects of four compounds from Gentianella acuta (Michx.) Hulten on hydrogen peroxide-induced injury in H9c2 cells. Biomed Res Int. 2019:26929702019. View Article : Google Scholar :
41	Tungmunnithum D, Thongboonyou A, Pholboon A and Yangsabai A: Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: An overview. Medicines (Basel). 5:E932018. View Article : Google Scholar
42	Hammad S, Cavalcanti E, Werle J, Caruso ML, Dropmann A, Ignazzi A, Ebert MP, Dooley S and Giannelli G: Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model. Arch Toxicol. 92:2297–2309. 2018. View Article : Google Scholar : PubMed/NCBI
43	Luangmonkong T, Suriguga S, Adhyatmika A, Adlia A, Oosterhuis D, Suthisisang C, de Jong KP, Mutsaers HAM and Olinga P: In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β. Toxicol Appl Pharmacol. 355:127–137. 2018. View Article : Google Scholar : PubMed/NCBI